@article{ATM33790,
author = {Jeremy D. Kratz and Dustin A. Deming},
title = {The evolving treatment paradigm for BRAF V600 mutant colorectal cancer},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 8},
year = {2019},
keywords = {},
abstract = {Metastatic colorectal cancer (CRC) is now being better understood as a collection of diseases with each distinguished by distinct molecular profiles. BRAF mutant cancers are an important CRC subtype composing about 10% of metastatic CRCs. Of those with a mutation in the BRAF gene, 80% possess the V600E mutation (1).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/33790}
}